期刊
CHEMMEDCHEM
卷 18, 期 12, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202300063
关键词
alkylation; 5-alkoxypyrazoles; analgesia; partial agonists; the transient receptor potential vanilloid 1 (TRPV1); molecular docking
Chemoselective O-alkylation of 1-aryl-3-polyfluoroalkylpyrazol-5-oles under basic conditions yielded a series of 5-alkoxypyrazoles (26 derivatives). They exhibited acceptable drug-like properties, as determined by in silico ADME profiling. In vivo experiments demonstrated that these compounds were non-toxic at doses greater than 150 mg/kg (most compounds were non-toxic at doses >300 mg/kg, and the lead compounds were non-toxic at doses >600 mg/kg).
Chemoselective O-alkylation of 1-aryl-3-polyfluoroalkylpyrazol-5-oles under basic conditions resulted in a series of 5-alkoxypyrazoles (26 derivatives). They showed an acceptable ADME profile (in silico) and can be considered as drug-like. In experiments in vivo (CD-1 mice), it was found that the obtained compounds do not have toxic properties at a dose of more than 150 mg/kg (for most compounds at a dose of >300 mg/kg, and for lead compounds - >600 mg/kg). 22 Compounds from this series demonstrated from moderate to high analgesic effects (28-104 % at 1 h and 37-109 % at 2 h after administration) in vivo in the hot plate test (SD rats, 15 mg/kg, intraperitoneal (ip)). The lead compound was 4-([1-phenyl-3-(trifluoromethyl)pyrazol-5-yl]oxy)butan-1-ol, which not only increased the latent period in the hot plate test by 103 % at both measurement points but also showed a pronounced analgesic effect under conditions of capsaicin-induced nociception (CD-1 mice, 15 mg/kg, ip). According to molecular modeling, all synthesized compounds can interact with the TRPV1 ion channel. This biological target was confirmed in in vitro experiments on Chinese hamster ovary cells expressing rTRPV1. 5-Alkoxypyrazoles were partial agonists of the TRPV1 ion channel in various degree, and the most active was the same pyrazole as in in vivo tests.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据